Articles related to BIOMARKERS

This study unveils a blood-based biomarker test capable of identifying individuals at risk of Parkinson’s Disease and related dementias with remarkable precision, promising a new era in the proactive management of neurodegenerative disorders.

Explore the groundbreaking diagnostic capabilities of the p-tau217 test in Alzheimer’s disease, demonstrating high accuracy in detecting pathological markers and offering a new horizon in non-invasive diagnostic strategies.

Recent findings from UC Davis highlight the role of executive function challenges as early indicators in men with FMR1 premutations for developing fragile X-associated tremor/ataxia syndrome (FXTAS), presenting a new avenue for timely intervention.

Recent advancements in AI provide a promising avenue for the accurate and efficient diagnosis of autism spectrum disorder, leveraging retinal photography analysis to discern nuanced neurobiological variations.

Advanced biological aging, as measured by clinical biomarkers, increases one’s risk for dementia or stroke, despite adjustment for disease-specific risk factors. This finding underscores the potential of biological age as a predictor of neurological health.

The recent study from CTAD 2023 has demonstrated the potential of p-tau217 as a promising biomarker for preclinical Alzheimer’s disease. This finding could significantly enhance our ability to detect Alzheimer’s at its earliest stages and initiate timely interventions.